Page last updated: 2024-09-03

bw a868c and Colonic Neoplasms

bw a868c has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, T; Awata, A; Fujino, H; Murayama, T; Okura, I; Oyama, S; Regan, JW; Yamazaki, R1

Other Studies

1 other study(ies) available for bw a868c and Colonic Neoplasms

ArticleYear
A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.
    Archives of biochemistry and biophysics, 2014, Jan-01, Volume: 541

    Topics: Carcinogenesis; CD55 Antigens; Cell Line, Tumor; Colonic Neoplasms; Cyclic AMP; Dinoprostone; Drug Design; Gene Expression Regulation, Neoplastic; Humans; Hydantoins; Indoles; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; RNA, Messenger

2014